Ikarian Capital, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Ikarian Capital, Llc disclosed 118 stock positions valued at approximately $610.87M as of quarter-end June 30, 2026. The largest holdings include ABIVAX SA, KODIAK SCIENCES INC, and ALUMIS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 118
- Portfolio Value
- $610.87M
Holdings by Sector
Ikarian Capital, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ABIVAX SA | ABVX | Healthcare | 7.10% | 328,635 | +271,000 | +470.20% | $43,352,978 |
| KODIAK SCIENCES INC | KOD | Healthcare | 6.76% | 1,059,730 | -206,065 | -16.28% | $41,287,080 |
| ALUMIS INC | ALMS | Healthcare | 4.01% | 870,548 | -343,000 | -28.26% | $24,497,220 |
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 3.99% | 72,842 | +1,261 | +1.76% | $24,386,773 |
| VAXCYTE INC | PCVX | Healthcare | 3.70% | 388,682 | -40,000 | -9.33% | $22,594,085 |
| ANI PHARMACEUTICALS INC | ANIP | Healthcare | 3.69% | 272,085 | +125,000 | +84.98% | $22,523,196 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 2.91% | 478,500 | +17,253 | +3.74% | $17,804,985 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 2.55% | 504,559 | +504,559 | +100.00% | $15,555,555 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 2.43% | 2,148,359 | -540,000 | -20.09% | $14,866,644 |
| CAPRICOR THERAPEUTICS INC | CAPR | Healthcare | 2.38% | 604,215 | +76,200 | +14.43% | $14,549,497 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 2.34% | 370,084 | +370,084 | +100.00% | $14,322,251 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 2.18% | 310,000 | +110,000 | +55.00% | $13,302,100 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 2.17% | 807,874 | - | - | $13,241,056 |
| TENAX THERAPEUTICS INC | TENX | Healthcare | 1.88% | 787,600 | -230,000 | -22.60% | $11,459,580 |
| C4 THERAPEUTICS INC | CCCC | Healthcare | 1.86% | 2,433,000 | +2,433,000 | +100.00% | $11,362,110 |
| MAZE THERAPEUTICS INC | MAZE | Other | 1.85% | 378,999 | - | - | $11,309,331 |
| CONNECT BIOPHARMA HLDGS LTD | CNTB | Other | 1.77% | 4,538,534 | -849,952 | -15.77% | $10,801,710 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 1.76% | 407,338 | -107,662 | -20.91% | $10,749,651 |
| PHARVARIS N V | PHVS | Other | 1.75% | 308,856 | -178,000 | -36.56% | $10,680,241 |
| JADE BIOSCIENCES INC | JBIO | Other | 1.55% | 427,349 | -85,000 | -16.59% | $9,495,694 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 1.28% | 425,000 | +425,000 | +100.00% | $7,807,251 |
| PELTHOS THERAPEUTICS INC | PTHS | Other | 1.19% | 256,598 | - | - | $7,251,459 |
| ZURA BIO LTD | ZURA | Other | 1.18% | 1,218,492 | +25,000 | +2.09% | $7,189,102 |
| TECTONIC THERAPEUTIC INC | TECX | Healthcare | 1.16% | 205,837 | +48,300 | +30.66% | $7,075,647 |
| SPRUCE BIOSCIENCES INC | SPRB | Other | 1.07% | 121,356 | - | - | $6,553,224 |
| HIMS & HERS HEALTH INC | HIMS | Consumer Defensive | 1.07% | 188,381 | +188,381 | +100.00% | $6,531,170 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 1.05% | 126,541 | +126,541 | +100.00% | $6,421,957 |
| PROQR THRAPEUTICS N V | PRQR | Other | 1.04% | 3,425,930 | +1,933,701 | +129.58% | $6,372,230 |
| BRIGHT MINDS BIOSCIENCES INC | DRUG | Other | 1.02% | 88,951 | -77,696 | -46.62% | $6,244,361 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.00% | 2,269,704 | -625,000 | -21.59% | $6,105,503 |
Showing 30 of 118 holdings in the latest reporting period.
Ikarian Capital, Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 300,000 | $47,475,000 |
| Q2 2026 | ABVX | Abivax SA | CALL | 341,100 | $45,454,986 |
| Q2 2026 | ABVX | Abivax SA | PUT | 250,000 | $33,315,000 |
| Q2 2026 | IONS | Ionis Pharmaceuticals, Inc. | CALL | 400,000 | $31,716,000 |
| Q2 2026 | MRNA | Moderna, Inc. | PUT | 400,000 | $28,012,000 |
| Q2 2026 | IONS | Ionis Pharmaceuticals, Inc. | PUT | 300,000 | $23,787,000 |
| Q2 2026 | ALMS | Alumis Inc. | CALL | 356,300 | $10,026,282 |
| Q2 2026 | KOD | Kodiak Sciences Inc | CALL | 217,700 | $8,481,592 |
| Q2 2026 | CAPR | Capricor Therapeutics, Inc. | CALL | 350,000 | $8,428,000 |
| Q2 2026 | ARWR | Arrowhead Pharmaceuticals, Inc. | PUT | 100,000 | $8,151,000 |
| Q2 2026 | PRAX | Praxis Precision Medicines, Inc | CALL | 20,000 | $6,695,800 |
| Q2 2026 | KYMR | Kymera Therapeutics, Inc. | PUT | 50,400 | $5,779,368 |
| Q2 2026 | TENX | Tenax Therapeutics, Inc. | CALL | 373,100 | $5,428,605 |
| Q2 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | CALL | 370,400 | $5,296,720 |
| Q2 2026 | SLS | SELLAS Life Sciences Group, Inc | PUT | 354,700 | $5,235,372 |
| Q2 2026 | SION | Sionna Therapeutics | PUT | 107,500 | $4,728,925 |
| Q2 2026 | CLDX | Celldex Therapeutics, Inc. | PUT | 114,000 | $4,241,940 |
| Q2 2026 | VERA | Vera Therapeutics, Inc. | CALL | 71,700 | $3,076,647 |
| Q2 2026 | QTTB | Q32 Bio Inc. | PUT | 200,000 | $2,548,000 |
| Q2 2026 | OLMA | Olema Pharmaceuticals, Inc. | CALL | 200,000 | $2,502,000 |
| Q2 2026 | BMY | Bristol-Myers Squibb Company | PUT | 42,500 | $2,448,850 |
| Q2 2026 | IRON | Disc Medicine, Inc. | CALL | 13,300 | $972,762 |
| Q2 2026 | ELTX | Elicio Therapeutics, Inc. | CALL | 107,100 | $418,761 |
| Q2 2026 | PRAX | Praxis Precision Medicines, Inc | PUT | 900 | $301,311 |
| Q2 2026 | TENX | Tenax Therapeutics, Inc. | PUT | 16,500 | $240,075 |
Showing 25 of 25 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.